Literature DB >> 15035276

Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm.

James K Liu1, Michael S Tenner, Oren N Gottfried, Edwin A Stevens, Joshua M Rosenow, Neel Madan, Joel D MacDonald, John R W Kestle, William T Couldwell.   

Abstract

OBJECT: Cerebral vasospasm that is caused by aneurysmal subarachnoid hemorrhage and that is refractory to maximal medical management can be treated with selective intraarterial papaverine infusions. The effects of single papaverine treatments on cerebral circulation time are well known. The purpose of this study was to assess the efficacy of multiple, repeated papaverine infusions on the cerebral circulation time in patients with recurrent vasospasm.
METHODS: A retrospective study was conducted in 17 patients who received multiple intraarterial papaverine infusions in 91 carotid artery (CA) territories for the treatment of cerebral vasospasm. Cerebral circulation times were measured from the first angiographic image, in which peak contrast was seen above the supraclinoid internal CA, to the peak filling of cortical veins. Glasgow Outcome Scale (GOS) scores assessed 12 months after discharge were reviewed. Cerebral circulation times in 16 CA territories were measured in a control group of 11 patients. Seventeen patients received a total of 91 papaverine treatments. Prolonged cerebral circulation times improved after 90 (99%) of 91 papaverine treatments. The prepapaverine mean cerebral circulation time was 6.54 seconds (range 3.35-27 seconds) and the immediate postpapaverine mean cerebral circulation time was 4.19 seconds (range 2.1-12.6 seconds), an overall mean decrease of 2.35 seconds (36%, p < 0.001). Recurrent vasospasm reflected by prolonged cerebral circulation times continued to improve with subsequent papaverine infusions. Repeated infusions were just as successful quantitatively as the primary treatment (mean change 2.06 seconds). The mean cerebral circulation time in the control group was 5.21 seconds (range 4-6.8 seconds). In five patients a dramatic reversal of low-attenuation changes was detected on computerized tomography scans. The mean GOS score at 12 months after discharge was 3.4.
CONCLUSIONS: The preliminary results indicate that multiple intraarterial papaverine treatments consistently improve cerebral circulation times, even with repeated infusions in cases of recurrent vasospasm.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15035276     DOI: 10.3171/jns.2004.100.3.0414

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  17 in total

1.  Intra-arterial papaverine used to treat cerebral vasospasm reduces brain oxygen.

Authors:  Michael F Stiefel; Alejandro M Spiotta; Joshua D Udoetuk; Eileen Maloney-Wilensky; John B Weigele; Robert W Hurst; Peter D LeRoux
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 2.  Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage.

Authors:  James K Liu; William T Couldwell
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Critical care guidelines on the endovascular management of cerebral vasospasm.

Authors:  Matthew M Kimball; Gregory J Velat; Brian L Hoh
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 4.  Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature.

Authors:  Guilherme Dabus; Raul G Nogueira
Journal:  Interv Neurol       Date:  2013-10

5.  Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.

Authors:  W-S Cho; H-S Kang; J E Kim; O-K Kwon; C W Oh; Y J Son; B J Know; C Jung; M H Hang
Journal:  Interv Neuroradiol       Date:  2011-06-20       Impact factor: 1.610

6.  Symptomatic carotid vasospasm caused by a distal-protection device during stent angioplasty of the right internal carotid artery.

Authors:  Rajesh Vijayvergiya; Parminder S Otaal; Shiv Bagga; Manish Modi
Journal:  Tex Heart Inst J       Date:  2010

7.  Assessment of changes in cerebral circulation time due to vasospasm in a specific arterial territory: effect of angioplasty.

Authors:  B Turowski; R du Mesnil de Rochemont; J Beck; J Berkefeld; F E Zanella
Journal:  Neuroradiology       Date:  2005-02-10       Impact factor: 2.804

8.  Disruption of the blood-brain barrier by intra-arterial administration of papaverine: a technical note.

Authors:  Johannes Platz; Krisztina Baráth; Emanuela Keller; Anton Valavanis
Journal:  Neuroradiology       Date:  2008-09-13       Impact factor: 2.804

9.  Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage.

Authors:  Kelly Goodson; Marc Lapointe; Timothy Monroe; Julio A Chalela
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

10.  Synthesis, acoustic stability, and pharmacologic activities of papaverine-loaded echogenic liposomes for ultrasound controlled drug delivery.

Authors:  Patrick H Kee; Todd A Abruzzo; Denise A B Smith; Jonathan A Kopechek; Boyu Wang; Shaoling L Huang; Robert C MacDonald; Christy K Holland; David D McPherson
Journal:  J Liposome Res       Date:  2008       Impact factor: 3.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.